Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
β | CI | p | β | CI | p | |
Age (years) | −0. 32 | (−1.15, 0.51) | 0.4 | |||
BMI | −0.15 | (−0.96, 0.65) | 0.7 | |||
Time since JIA onset (years) | −0.52 | (−1.74, 0.69) | 0.4 | |||
JIA subtype | ||||||
Oligoarthritis | 0 | |||||
Systemic-onset arthritis | −0.92 | (−8.81, 6.96) | 0.8 | |||
Polyarticular forms | −0.55 | (−7.61, 6.50) | 0.8 | |||
CHAQ | −3.28 | (−7.31, 0.75) | 0.1 | |||
Patient global health (cm) | −0.17 | (−0.35, −0.004) | 0.04 | −0.6 | (−0.50, 0.38) | 0.7 |
Tender joints | −0.79 | (−1.47, −0.10) | 0.02 | −1.23 | (−3.76, 1.30) | 0.3 |
Swollen joints | −0.67 | (−1.78, 0.42) | 0.2 | |||
ESR (mm/h) | −0.14 | (−0.28, 0.004) | 0.05 | −0.21 | (−0.66, 0.23) | 0.3 |
DAS28 | −3.87 | (−7.67, −0.07) | 0.04 | 4.02 | (−0.66, 0.23) | 0.6 |
BASDAI | −1.88 | (−6.40, 2.62) | 0.3 | |||
Medications used: | ||||||
NSAID | 1.45 | (−6.67, 9.57) | 0.7 | |||
Corticosteroid | 1.08 | (−6.04, 8.2) | 0.7 | |||
Methotrexate | −3.63 | (−10.73, 3.46) | 0.3 | |||
Sulfassalazine | −0.04 | (−9.91, 9.83) | 0.9 | |||
Biologics | 1.56 | (−11.81, 14.94) | 0.81 |